Skip to content
Screener

Intangibles (Net) at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$3.68B+25.7%
Sotera Health logo
Sotera HealthSHC
$270.17M-10.0%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$44.39M-32.9%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$586.8M-10.3%
Revvity logo
RevvityRVTY
$2.31B-10.3%
IQVIA logo
IQVIAIQV
$4.75B+3.3%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemJune 27, 2026December 27, 2025
Venture capital and strategic equity investments206,470206,972
Operating lease right-of-use assets, net330,247361,415
Goodwill3,076,8512,764,253
Intangible assets, net253,174339,995
Deferred tax assets53,82767,334
Other assets587,556293,185
Total assets$7,532,145$7,135,422
Liabilities, Redeemable Noncontrolling Interests and Equity

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's intangibles (net)?
Charles River Laboratories (CRL) reported intangibles (net) of $253.17M in Q2 2026.
How has Charles River Laboratories's intangibles (net) changed year-over-year?
Charles River Laboratories's intangibles (net) decreased by 58.0% year-over-year, from $602.45M to $253.17M.
What is the long-term trend for Charles River Laboratories's intangibles (net)?
Over 5 years (2020 to 2025), Charles River Laboratories's intangibles (net) has grown at a -15.5% compound annual growth rate (CAGR), from $787.6M to $340M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.

Ask your AI about Charles River Laboratories's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude